Neuromuscular function and plasma drug levels in pyridostigmine treatment of myasthenia gravis.

In 18 patients with generalised myasthenia treated with oral pyridostigmine, muscular strength, decrement of neuromuscular transmission in the trapezius muscle on repetitive accessory nerve stimulation, and pyridostigmine plasma level were measured repeatedly during 1-3 dosing intervals. Significant...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Neurol Neurosurg Psychiatry
Principais autores:	Breyer-Pfaff, U, Schmezer, A, Maier, U, Brinkmann, A, Schumm, F
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 1990
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1014211/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2166138/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.53.6.502
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!